-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $105

Benzinga·05/06/2026 12:45:14
Listen to the news
Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and raises the price target from $103 to $105.